Correction: Biohit Oyj’s Annual Report 2019 is published

Biohit Oyj Correction

This is a correction to Biohit Oyj’s stock exchange release issued on March 27, 2020 at 5:37 p.m. The renumeration policy was incorrectly mentioned in the stock exchange release issued previously. The company has not published the renumeration policy yet.

Biohit Oyj Annual Financial Report

Biohit Oyj’s Annual Report 2019 is published today in PDF format. The annual report contains financial statements for 2019, the Report of the Board of Directors and Corporate Governance Statements. Annual report is published in Finnish and English, and it can be read and downloaded from Biohit company website:
https://www.biohithealthcare.com/en/investors/annual-reports/

Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

 

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com